Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 1535 beclometasone/formoterol pMDI PK crossover study in adolescents with asthma
2011-005108-14Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of beclometasone dipropionate + formoterol, beclomethasone dipropionate and formoterol in asthma (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Plasma AUC0-t for B17MP. Started Dec 2011; status: completed.
02
Drugs
beclometasone dipropionate + formoterolbeclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-005108-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005108-14.